Total Funding
3
Total FundingSeries C raised
Growth Score
pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
493719
Grand River Aseptic Manufacturing is a parenteral contract development and manufacturing organization.
Acquired by 
Arlington Capital Partners
Thomas Ross: President and CEO
John Wichelt: Vice-President, Client Pharmaceutical ServicesPast Role: Grand River Aseptic Manufacturing, Director of Quality Assurance and Regulatory Affairs
About the Company
Grand River Aseptic Manufacturing (GRAM), a parenteral contract development and manufacturing organization, delivers customized solutions to meet clients’ fill and finish needs from development through commercialization. With capabilities for biologics as well as controlled substances, GRAM’s expert project managers and modern facilities support
pharmaceutical development and cGMP manufacturing, analytical testing and regulatory filing.
